Maiko Nomoto

First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori et al. · Clinical Cancer Research · 2021 · 90 citations · Full text

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects

Maiko Nomoto, Gina Pastino, Bhaskar Rege et al. · Clinical Pharmacology in Drug Development · 2017 · 62 citations

Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle‐controlled exploratory trial

Osamu Nemoto, Nobukazu Hayashi, Yasumi Kitahara et al. · The Journal of Dermatology · 2015 · 42 citations

Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study

Fuminori Ohba, Shunji Matsuki, Shuhei Imayama et al. · Journal of Dermatological Treatment · 2016 · 41 citations

Pharmacokinetic/pharmacodynamic drug–drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs

Maiko Nomoto, Cynthia Zamora, Edgar Schuck et al. · British Journal of Clinical Pharmacology · 2018 · 26 citations · Full text